Labcorp Holdings Operating Expenses 2010-2025 | LH
Labcorp Holdings annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Labcorp Holdings operating expenses for the quarter ending March 31, 2025 were $3.019B, a 5.74% increase year-over-year.
- Labcorp Holdings operating expenses for the twelve months ending March 31, 2025 were $12.086B, a 4.34% increase year-over-year.
- Labcorp Holdings annual operating expenses for 2024 were $11.922B, a 4.25% increase from 2023.
- Labcorp Holdings annual operating expenses for 2023 were $11.436B, a 9.67% increase from 2022.
- Labcorp Holdings annual operating expenses for 2022 were $10.427B, a 3.37% increase from 2021.
| Labcorp Holdings Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $11,922 |
| 2023 | $11,436 |
| 2022 | $10,427 |
| 2021 | $10,088 |
| 2020 | $11,533 |
| 2019 | $10,225 |
| 2018 | $10,008 |
| 2017 | $9,003 |
| 2016 | $8,282 |
| 2015 | $7,683 |
| 2014 | $5,107 |
| 2013 | $4,817 |
| 2012 | $4,648 |
| 2011 | $4,594 |
| 2010 | $4,025 |
| 2009 | $3,759 |
| Labcorp Holdings Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $3,019 |
| 2024-12-31 | $3,113 |
| 2024-09-30 | $3,028 |
| 2024-06-30 | $2,926 |
| 2024-03-31 | $2,855 |
| 2023-12-31 | $3,156 |
| 2023-09-30 | $2,805 |
| 2023-06-30 | $2,767 |
| 2023-03-31 | $2,708 |
| 2022-12-31 | $2,229 |
| 2022-09-30 | $2,493 |
| 2022-06-30 | $2,494 |
| 2022-03-31 | $3,212 |
| 2021-12-31 | $552 |
| 2021-09-30 | $3,296 |
| 2021-06-30 | $3,137 |
| 2021-03-31 | $3,104 |
| 2020-12-31 | $3,197 |
| 2020-09-30 | $2,849 |
| 2020-06-30 | $2,471 |
| 2020-03-31 | $3,016 |
| 2019-12-31 | $2,617 |
| 2019-09-30 | $2,589 |
| 2019-06-30 | $2,546 |
| 2019-03-31 | $2,473 |
| 2018-12-31 | $2,480 |
| 2018-09-30 | $2,488 |
| 2018-06-30 | $2,497 |
| 2018-03-31 | $2,543 |
| 2017-12-31 | $2,414 |
| 2017-09-30 | $2,295 |
| 2017-06-30 | $2,198 |
| 2017-03-31 | $2,096 |
| 2016-12-31 | $2,058 |
| 2016-09-30 | $2,091 |
| 2016-06-30 | $2,065 |
| 2016-03-31 | $2,069 |
| 2015-12-31 | $2,068 |
| 2015-09-30 | $2,009 |
| 2015-06-30 | $1,946 |
| 2015-03-31 | $1,661 |
| 2014-12-31 | $1,300 |
| 2014-09-30 | $1,310 |
| 2014-06-30 | $1,270 |
| 2014-03-31 | $1,227 |
| 2013-12-31 | $1,222 |
| 2013-09-30 | $1,218 |
| 2013-06-30 | $1,199 |
| 2013-03-31 | $1,179 |
| 2012-12-31 | $1,190 |
| 2012-09-30 | $1,174 |
| 2012-06-30 | $1,147 |
| 2012-03-31 | $1,136 |
| 2011-12-31 | $1,119 |
| 2011-09-30 | $1,165 |
| 2011-06-30 | $1,178 |
| 2011-03-31 | $1,133 |
| 2010-12-31 | $1,057 |
| 2010-09-30 | $1,041 |
| 2010-06-30 | $968 |
| 2010-03-31 | $959 |
| 2009-12-31 | $949 |
| 2009-09-30 | $950 |
| 2009-06-30 | $944 |
| 2009-03-31 | $915 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.399B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.013B | 25.51 |
| CVS Health (CVS) | United States | $78.381B | 9.74 |
| Elevance Health (ELV) | United States | $62.395B | 8.39 |
| Cencora (COR) | United States | $56.765B | 19.75 |
| DiDi Global (DIDIY) | China | $26.874B | 28.55 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.991B | 0.00 |
| CochLear (CHEOY) | Australia | $13.143B | 0.00 |
| Solventum (SOLV) | United States | $12.678B | 13.42 |
| ICON (ICLR) | Ireland | $11.592B | 10.78 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Medpace Holdings (MEDP) | United States | $8.964B | 23.81 |
| Sonic Healthcare (SKHHY) | Australia | $8.852B | 0.00 |
| HealthEquity (HQY) | United States | $8.449B | 37.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.680B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.587B | 14.87 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.918B | 28.96 |
| BrightSpring Health Services (BTSG) | United States | $3.506B | 32.17 |
| Sotera Health (SHC) | United States | $3.139B | 17.84 |
| Surgery Partners (SGRY) | United States | $2.861B | 37.20 |
| Concentras Parent (CON) | United States | $2.507B | 14.49 |
| Organon (OGN) | United States | $2.459B | 2.61 |
| Alignment Healthcare (ALHC) | United States | $2.455B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.222B | 85.57 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.823B | 0.00 |
| Premier (PINC) | United States | $1.725B | 13.09 |
| GoodRx Holdings (GDRX) | United States | $1.672B | 33.43 |
| Ardent Health (ARDT) | United States | $1.589B | 6.77 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.202B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.878B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 7.10 |
| CareDx (CDNA) | United States | $0.663B | 10.36 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| So-Young (SY) | China | $0.595B | 0.00 |
| SBC Medicals (SBC) | United States | $0.585B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.479B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.402B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.312B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.297B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |